This study aimed to i/ develop a model allowing an in vivo demonstration of the involvement of the CaSR on metastatic tumor osteolytic potential and to ii/ investigate if CaSR activity could influence osteolysis though a mechanism different from PTHrP modulation. This evidence concerns the gene CASR and metastatic neoplasm.